期刊文献+

补硒对输尿管梗阻大鼠肾间质纤维化及结缔组织生长因子表达的影响 被引量:2

EFFECT OF SODIUM SELENITE ON RENAL INTERSTITIAL FIBROSIS AND EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR IN RATS WITH URETERAL OBSTRUCTION
原文传递
导出
摘要 目的探讨硒对单侧输尿管梗阻(UUO)模型大鼠肾间质纤维化的作用及其对肾间质结缔组织生长因子(CTGF)表达的影响。方法以单侧输尿管结扎致肾间质纤维化大鼠模型。将90只SD大鼠随机分为假手术组(A组)、UUO组(B组)、UUO+硒组(C组)、UUO+硒及维生素E组(D组)、UUO+苯那普利组(E组),每组18只。C、D、E组分别给予亚硒酸钠0.2 mg/(kg·d)、亚硒酸钠0.2 mg/(kg·d)+维生素E 200 mg/(kg·d)和亚硒酸钠0.2 mg/(kg-d)+亚苯那普利10 mg/(kg·d)灌胃。A、B组给予同等剂量生理盐水灌胃。术后第7、14、21 d各组随机处死6只大鼠,肾组织行HE、Masson染色评定各组肾间质纤维化程度,免疫组织化学半定量法检测各组肾间质结缔组织生长因子(CTGF)和转化生长因子-β1(TGF-β1)的表达。Western印迹法检测肾组织CTGF蛋白表达。化学比色法检测肾组织谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)的含量。结果术后第7,14,21 d,C组肾间质纤维化程度较B组明显减轻(P<0.05),肾组织CTGF和TGF-β1的表达强度明显低于B组(P<0.01或P<0.05),GSH-Px和SOD含量明显高于B组(P<0.05),MDA含量明显低于B组(P<0.05)。B组肾组织中CTGF和TGF-β1的表达以及肾间质纤维化指数与MDA含量呈显著正相关(P<0.05),而与SOD、GSH-Px含量呈显著负相关(P<0.05)。结论亚硒酸钠可以减轻UUO模型大鼠肾间质纤维化程度,其机制可能与硒的抗氧化作用、抑制肾组织TGF-β1、CTGF的表达有关。 Objective To investigate the effect of sodium selenite on renal interstitial fibrosis in rat model of unilateral ureteral obstruction (UUO). Methods Ninety male SD rats were randomly divided into 5 groups: sham-operation group (group A), UUO group (group B), UUO+sodium selenite group (group C), UUO+sodium selenite and vitamin E group (group D), UUO + benazepril group (group E), with 18 in each group. Group C received sodium selenite 0.2 mg/(kg.d), Group D received sodium selenite 0.2 mg/(kg.d)+ Vitamin E 200 mg/(kg.d) and group E received sodium selenite 0.2 mg (kg ~ d)+ benazepril 10 mg/(kg'd) by gastric perfusion. A,B groups were given the equal volume 6f saline. At day 7, 14 and 21 after treatment, 6 rats were selected randomly from each group and killed. The extent of renal interstitial fibrosis was evaluated by HE and Masson staining. Immunohistochemical method and Western blot were used to estimate the expression of connective tissue growth factor (CTGF) and transforming growth factor-J31 (TGF-D1). Renal cortex supper oxide dismutase (SOD), malondialdehyde (MDA) and glutathione peroxidase (GSH-Px) were measured by colorimetric assay Results The extent of renal interstitial fibrosis and the expression of CTGF and TGF-[31 in renal cortex were significantly lower in group C at day 7, 14 and 21 after operation compared with that in group B (P^0.05 or P〈0.01 ) . In group C, the contents of SOD and GSH-Px in renal cortex were higher significantly than those in group B at day 7,14 and 21 respectively (P〈0.05) , but MDA in renal cortex was significantly decreased (P^0.05) . There were no significant differences in the extent of renal interstitial fibrosis, the expression of TGF-~l in renal cortex, the contents of SOD, GSH-Px and MDA in renal cortex among group C, D and E (P^0.05). The expression of CTGF and TGF-[31 in renal cortex, and the extent of renal interstitial fibrosis was positively correlated to the level of MDA in group B (r = 0.843, P^0.05: r = 0.855, P^0.05; r = 0.818, P〈0.05, respectively) , and negatively correlated to the level of SOD (r =- 0.852, P〈0.05: r = -0.819, P〈0.05; r =- 0.824, P〈0.05, respectively) and GSH-Px (r = -0.875, P〈0.05: r = -0.837,P〈0.05: r = -0.832, P〈0.05,respectively) . Conelusion Sodium selenite may reduce the extent of renal fibrosis in rat UUO model.This effect may be related to antioxidant function and down-regulation of the expression of CTGF and TGF-1 in renal tissue.
出处 《营养学报》 CAS CSCD 北大核心 2013年第5期460-466,共7页 Acta Nutrimenta Sinica
基金 杭州市科技计划发展项目(No.20080333B19)
关键词 单侧输尿管梗阻 氧化应激 转化生长因子-β1 结缔组织生长因子 肾间质纤维化 selenium unilateral ureteral obstruction oxidative stress connective tissue growth factor transforming growth faetor-pl renal interstitial fibrosis
  • 相关文献

参考文献13

  • 1Kim], lung K], Park KM. Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury[J]. AmJ Physiol Renal Phy s io I, 2010, 298: FllI81l29.
  • 2Leask A, Holmes A, Black CM, et al. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor betal in fibroblasts[J].J BioI Chem, 2003, 278: 13008-13015.
  • 3Ql W, Twigg S, Chen X, et al. Integrated actions of transforming growth factor betal and connective tissue growth factor in renal fibrosis[J]. AmJ Phy s i o I Renal Physiol, 2005, 288: 800-809.
  • 4Mezzano SA, Droguett MA, Burgos ME, et ai. Overexpre?ssion of chemokines, fibrogenetic cytokines, and myofi?broblasts in human membranous nephropathy[J]. Kidney Int, 2000, 57: 147-158.
  • 5赵班,吴华,郑法雷.红细胞生成素对单侧输尿管梗阻大鼠肾间质纤维化的作用及对MCP-1和TGF-β1表达的影响[J].中国血液净化,2010,9(9):477-481. 被引量:7
  • 6Klahr S,]eremiab M. Obstructive nephropathy and renal fibrosis[J]. Kidney Int., 2004, 56: 295303.
  • 7Han DC, Hffman BB, Hong SW, et al. Therapy wi th antisen?se TGF-beta I 01 igodeoxynucleotides reduces kidney weight and matrix mRNA in diabetic mice[J]. AmJ Physioi Renal Phv s io l, 2000, 278: F628634.
  • 8Stanton RC. Oxidative stress and diabetic kidney disease[J]. Curr Diab Rep, 2011, II: 330-336.
  • 9Yuan XP, Liu LS,Fu Q, et ai. Effects of ligustrazine on ureteral obstruction-induced renal tubulointerstitial fibrosis[J]. Phytother Res, 2012,26: 697-703.
  • 10刘伏友.蛋白尿致肾小管间质纤维化的机制及防治[J].中华肾脏病杂志,2006,22(5):258-260. 被引量:39

二级参考文献20

  • 1Okada H, Strutz F, Danoff TM, et al. Progresstion of chronic renal disease[J]. Contrib Nephrol. Basal, Karger, 1996, 118:147-154.
  • 2Eddy A. Molecular basis of renal fibrosis[J]. Pediatr Nephrol, 2000,15:290-301.
  • 3Roth D, Smith RD, Schulman G, et al. Effects of recombinant human erythpoietin therapy on renal function in chronic renal failur predialysis patients[J]. Am J Kidney Dis, 1994,24:777-784.
  • 4Feldman L, Sytkowski AJ. Pleitropic action of erythropoietin [J]. Environ Health Prev Med, 2003, 7:239-245.
  • 5Westenfelder C. Human, rat, and mouse kidney cells express functional erythropoietin receptors[J]. Kidney Int, 1999,55:808- 820.
  • 6Kuriyama S, Tomonari H, Yoshida H, et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure,especially in nondiabetic patients [J]. Nephron, 1997,77:176-185.
  • 7Jungers P, Choukroun G, Oualim Z, et al. Beneficial influence of rhuEPO therapy on the rate of progression of chronic renal failure in predialysis patients[J]. Nephrol Dial Transplant, 2001, 16:307-312.
  • 8Sharples EJ, Patel N, Brown P, et al. Erythropoetin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion[J]. J Am Soc Nephol, 2004,15: 2115- 2124.
  • 9Bahlmann FH, Song R, Boehm SM, et al. Low-dose therapy with the long acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenu ates progressive organ failure[J]. Circulation, 2004,110: 1006-1012.
  • 10Lee SH, Li C, Lim SW, et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythro poietin in chronic cyclosporine nephropathy[J]. Am J Nephrol, 2005,25:64- 76.

共引文献43

同被引文献18

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部